Amgen
$403.04Change from previous close: −1.04%Absolute change: −$4.23
At a glance
- Revenue growth
- +9.95%
- 2025 vs 2024
- Net income growth
- +88.53%
- 2025 vs 2024
- Net margin
- 21.0%
- 2024: 12.2%
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 9,958 | 11,490 | 8,471 | 9,721 | 9,261 | 10,497 | 9,150 | 11,296 | 11,177 | 10,354 |
| Depreciation and amortization | 5,167 | 5,592 | 4,071 | 3,417 | 3,398 | 3,601 | 2,035 | 1,930 | 1,904 | 2,105 |
| Capital expenditure | -1,858 | -1,096 | -1,112 | -936 | -880 | -608 | -618 | -738 | -664 | -738 |
| Investing cash flow | -1,943 | -1,046 | -26,204 | -6,044 | 733 | -5,401 | 5,709 | 14,339 | -4,024 | -8,658 |
| Financing cash flow | -10,859 | -9,415 | 21,048 | -4,037 | -8,271 | -4,867 | -15,767 | -22,490 | -6,594 | -2,599 |
| Dividends paid | -5,124 | -4,832 | -4,556 | -4,196 | -4,013 | -3,755 | -3,509 | -3,507 | -3,365 | -2,998 |
| Share repurchases | 0.0 | -200 | 0.0 | -6,360 | -4,975 | -3,486 | -7,702 | -17,794 | -3,351 | -3,225 |
| Debt issued | 0.0 | 0.0 | 27,777 | 6,919 | 4,945 | 8,914 | — | — | 4,476 | 7,318 |
| Debt repaid | -5,683 | -4,259 | -2,101 | -297 | -4,150 | -6,450 | -4,514 | -1,121 | -4,405 | -3,725 |
| Net change in cash | -2,844 | 1,029 | 3,315 | -360 | 1,723 | 229 | -908 | 3,145 | 559 | -903 |
| Free cash flow | 8,100 | 10,394 | 7,359 | 8,785 | 8,381 | — | — | — | — | — |
| Levered free cash flow | 7,502 | 13,726 | 3,392 | 8,690 | 7,515 | 9,228 | 6,465 | 7,912 | 8,411 | 6,628 |